Skip to main content
SpringerLink
Log in

Chlamydial infections and the quinolones

  • Review
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Some of the newer fluoroquinolones may be suitable agents for the treatment ofChlamydia trachomatis infections and non-gonococcal urethritis. To date, small studies with both ofloxacin and fleroxacin appear to achieve cure rates of 85–100% for urethritis and cervicitis due toChlamydia trachomatis. However, large well-designed clinical trials are required to determine the efficacy and acceptance of these and other fluoroquinolones in the treatment of patients with genital or respiratory syndromes due to chlamydiae or other bacterial pathogens causing infections with similar manifestations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ehret JM, Judson FN Susceptibility testing ofChlamydia trachomatis: from eggs to monoclonal antibodies. Antimicrobial Agents and Chemotherapy 1988, 32: 1295–1299.

    PubMed  Google Scholar 

  2. Sheppard MK, Jones RB Recovery ofChlamydia trachomatis from endometrial and fallopian tube biopsies in women with infertility of tubal origin. Fertility and Sterility 1989, 52: 232–238.

    PubMed  Google Scholar 

  3. Toomey KE, Barnes RC Treatment ofChlamydia trachomatis genital infection. Reviews of Infectious Diseases 1990, 12, Supplement 6: 645–655.

    Google Scholar 

  4. Jones RB, Van Der Pol B Chlamydiatrachomatis isolates resistant to multiple antibiotics. In: Bowie WR, Caldwell HD, Jones RP, Mardh PA, Ridgway GL, Schachter J, Stamm WE, Ward ME (ed): Chlamydial infections. Cambridge University Press, Cambridge 1990, p. 519–522.

    Google Scholar 

  5. Pocidalo JJ Use of fluoroquinolones for intracellular pathogens. Reviews of Infectious Diseases 1989, 11, Supplement 5: 979–984.

    Google Scholar 

  6. Batteiger BE, Jones RB, White A Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease. American Journal of Medicine 1989, 87, Supplement 6C: 75–77.

    Google Scholar 

  7. Oriel JD Use of quinolones in chlamydial infection. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1273–1276.

    Google Scholar 

  8. Stein GE, Saravolatz LD Randomized clinical study of ofloxacin and doxycycline in the treatment of nongonococcal urethritis and cervicitis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1277.

    Google Scholar 

  9. Tack KJ, Callery SV, Smith JA, Beitler PJ, Vance J Ofloxacin in the treatment of sexually transmitted diseases. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1282–1283.

    Google Scholar 

  10. Nayagam AT, Ridgway GL, Oriel JD Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused byChlamydia trachomatis in men and women. Journal of Antimicrobial Chemotherapy 1988, 22, Supplement C: 155–158.

    Google Scholar 

  11. Kuo CC, Grayston JT In vitro drug susceptibility ofChlamydia spp. strain TWAR. Antimicrobial Agents and Chemotherapy 1988, 32: 257–258.

    PubMed  Google Scholar 

  12. Ridgway GL, Fenelon LE, Mumtaz G The in vitro antibiotic susceptibility ofChlamydia pneumoniae. In: Bowie WR, Caldwell HD, Jones RP, Mardh PA, Ridgway GL, Schachter J, Stamm WE, Ward ME (ed): Chlamydial infections. Cambridge University Press, Cambridge 1990, p. 531–533.

    Google Scholar 

  13. Gundersen T, Zahm F Fleroxacin in the treatment of urogenital infections caused byChlamydia trachomatis: a pilot study. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1278.

    Google Scholar 

  14. Soltz-Szors J, Schneider S, Mailer H Efficacy of and tolerance to fleroxacin in the treatment of chlamydial urethritis and cervicitis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1280–1281.

    Google Scholar 

  15. Bowie WR, Willetts V, Megran DW Dose-ranging study of fleroxacin for treatment of uncomplicatedChlamydia trachomatis gential infections. Antimicrobial Agents and Chemotherapy 1989, 33: 1774–1777.

    PubMed  Google Scholar 

  16. Mogabgab WJ, Holmes B, Murray M, Beville R, Lutz FB, Tack KJ Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis. Chemotherapy 1990, 36: 70–76.

    PubMed  Google Scholar 

  17. Hooper DC, Wolfson JS Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects. Antimicrobial Agents and Chemotherapy 1989, 33: 1662–1667.

    PubMed  Google Scholar 

  18. Jones RB Treatment ofChlamydiatrachomatis infections of the urogenital tract. In: Bowie WR, Caldwell HD, Jones RP; Mardh PA, Ridgway GL, Schachter J, Stamm WE, Ward ME (ed): Chlamydial infections. Cambridge University Press, Cambridge 1990, p. 509–518.

    Google Scholar 

  19. Stamm WE Laboratory diagnosis of chlamydial infection. In: Bowie WR, Caldwell HD, Jones RP, Mardh PA, Ridgway GL, Schachter J, Stamm WE, Ward ME (ed): Chlamydial infections. Cambridge University Press, Cambridge 1990, p. 459–470.

    Google Scholar 

  20. Obata I, Hayashi M, Imagawa N, Hayashi S, Yamata T, Terashima Y, Saito K, Niki T Efficacy of ofloxacin against obstetric and gynecologic infections due toChlamydia trachomatis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1281–1282.

    Google Scholar 

  21. Schachter J, Moncada JV In vitro activity of ofloxacin againstChlamydia trachomatis. American Journal of Medicine 1989, 87, Supplement 6C: 14–16.

    Google Scholar 

  22. Clad A, Flohr P, Petersen EE Genital isolates ofChlamydiatrachomatis survive 12 day antibiotic treatment in vitro due to delayed cell lysis. In: Bowie WR, Caldwell HD, Jones RP, Mardh PA, Ridgway GL, Schachter J, Stamm WE, Ward ME (ed): Chlamydial infections. Cambridge University Press, Cambridge 1990, p. 523–526.

    Google Scholar 

  23. Segreti J, Hirsch DJ, Harris AA, Kapell KS, Orbach H, Kessler HA In vitro activity of tosulfloxacin (A-61827; T-3262) against selected genital pathogens. Antimicrobial Agents and Chemotherapy 1990, 34: 971–973.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, University of Manitoba, Room 543, 730 William Avenue, R3E OW3, Winnipeg, Manitoba, Canada

    A. R. Ronald & R. W. Peeling

Authors
  1. A. R. Ronald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. W. Peeling
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ronald, A.R., Peeling, R.W. Chlamydial infections and the quinolones. Eur. J. Clin. Microbiol. Infect. Dis. 10, 351–354 (1991). https://doi.org/10.1007/BF01967010

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967010

Keywords

Search

Navigation